covid 19 News and Research

RSS

IVI successfully completes the '2022 Introductory Course for Biologics Development and Manufacturing'

The International Vaccine Institute (IVI) successfully completed the '2022 Introductory Course for Biologics Development and Manufacturing' on July 29 to train 106 participants from 24 low- and middle-income countries (LMICs) and 32 from the Republic of Korea.

29 Jul 2022

Reducing COVID-19–related surgical backlog using innovative models of service delivery

JMIR Publications recently published "A Canadian Weekend Elective Pediatric Surgery Program to Reduce the COVID-19–Related Backlog: Operating Room Ramp-Up After COVID-19 Lockdown Ends-;Extra Lists (ORRACLE-Xtra) Implementation Study" in JMIR Perioperative Medicine which reported that a decrease in surgical services led to substantial backlogs for time-sensitive scheduled pediatric patients.

29 Jul 2022

Study uses Twitter data to understand stigma against people with dementia during the pandemic

JMIR Publications recently published "Using Twitter to Examine Stigma Against People With Dementia During COVID-19: Infodemiology Study" in JMIR Aging which reported that during the pandemic, there has been significant social media attention focused on the increased COVID-19 risks and impacts for people with dementia and their care partners.

29 Jul 2022

Survey: Nearly 1 in 5 Americans are concerned about contracting monkeypox

As Covid-19 cases surge across the United States dominated by a highly transmissible subvariant and worry about Covid persists, some in the public have begun to voice concern about the new health threat of monkeypox, according to a new Annenberg Public Policy Center national survey.

29 Jul 2022

Study finds asymptomatic SARS-CoV-2 infection induced comparable memory B cell responses to mild symptomatic infection in young adults

Researchers identified that among healthy young adults, the development of SARS-CoV-2 triggered memory B cell and antibody reactions were equivalent following mildly symptomatic or asymptomatic infections.

29 Jul 2022

RINVOQ® (upadacitinib) Approved by European Commission as an Oral Treatment for Adults with Active Non-Radiographic Axial Spondyloarthritis

With this approval, RINVOQ® is the first and only Janus Kinase inhibitor approved to treat patients across the spectrum of axial spondyloarthritis (nr-axSpA and ankylosing spondylitis) in the EU.

From AbbVie 29 Jul 2022

SARS-CoV-2 spike subunit 2–targeted vaccine could more effectively combat all human coronaviruses

In a new study, researchers evidenced that the S2 subunit of SARS-CoV-2 spike (S) could be an integral component of a pan-coronavirus vaccine.

29 Jul 2022

One Health approach for emergent and resurgent infectious diseases

A recent editorial published in The Lancet Microbe underscored the ‘One Health’ policy for surveilling emergent infectious diseases.

29 Jul 2022

Tannins as therapeutic agents against SARS-CoV-2

Researchers reviewed tannins as therapeutic agents against SARS-CoV-2.

29 Jul 2022

Study explores the role of endemic coronaviruses-induced cross-immunity in protection against severe COVID-19

A new study investigated whether prior exposure to coronaviruses induces cross-reactive immunity that protects adults from severe coronavirus disease 2019.

29 Jul 2022

Proteomics profiling of COVID-19 patients identifies dysregulated proteins and pathways

Researchers assessed the impact of SARS-CoV-2 infection and severity on coronary and Alzheimer’s disease pathways.

29 Jul 2022

Vaccination after COVID-19 recovery reduces reinfection risk by almost 50%

Researchers estimated the probability of SARS-CoV-2 reinfection following COVID-19 recovery. Additionally, they determined the effectiveness of the primary vaccination series in reducing the reinfection risk.

29 Jul 2022

To what extent did the COVID-19 booster strategy prevent infections and hospitalizations in US adults?

Researchers estimated the impact of different COVID-19 mRNA booster vaccinations in the United States during fall 2022.

29 Jul 2022

Knowledge, attitudes, and practices of medical professionals towards monkeypox in Italy

Researchers assessed the knowledge, attitudes, and practices (KAP) of healthcare workers (HCWs) towards monkeypox (MPX) in Italy.

29 Jul 2022

AI-based tools have failed to reach the full diagnostic potential in COVID-19, study finds

Published by the Journal of Radiology: Artificial Intelligence, a prospective observational study across 12 hospital systems from the University of Minnesota Medical School evaluated the real-time performance of an interpretable artificial intelligence (AI) model to detect COVID-19 from chest X-rays.

29 Jul 2022

Study investigates the combined effects of aging and HIV-1 Tat expression in mice

A new research paper was published in Aging ("Aging (Albany NY)" by Medline/PubMed, "Aging-US" by Web of Science) Volume 14, Issue 13, entitled, "Age-related neuroendocrine, cognitive, and behavioral co-morbidities are promoted by HIV-1 Tat expression in male mice."

29 Jul 2022

Moderna COVID vaccine is more effective in older and sicker veterans over time

Researchers report the higher effectiveness of the Moderna COVID-19 vaccine as compared to the Pfizer COVID-19 vaccine.

28 Jul 2022

Study highlights impaired ketogenesis as a potential confounder of severe COVID-19

In severe Covid-19 patients, the metabolism produces insufficient amounts of certain energy-rich compounds called ketone bodies. However, these energy carriers are needed by two important cell types in the immune system in order to fight the virus effectively.

28 Jul 2022

The global mutation landscape of the SARS-CoV-2 non-structural protein 1

Researchers describe the evolution of the SARS-CoV-2 non-structural protein 1 (NSP1).

28 Jul 2022

Study offers a method to calculate chances of catching Covid-19 on a plane flight

What are the chances you will contract Covid-19 on a plane flight? A study led by MIT scholars offers a calculation of that for the period from June 2020 through February 2021.

28 Jul 2022

covid 19 News and Research

IVI successfully completes the '2022 Introductory Course for Biologics Development and Manufacturing'

Reducing COVID-19–related surgical backlog using innovative models of service delivery

Study uses Twitter data to understand stigma against people with dementia during the pandemic

Survey: Nearly 1 in 5 Americans are concerned about contracting monkeypox

Study finds asymptomatic SARS-CoV-2 infection induced comparable memory B cell responses to mild symptomatic infection in young adults

RINVOQ® (upadacitinib) Approved by European Commission as an Oral Treatment for Adults with Active Non-Radiographic Axial Spondyloarthritis

SARS-CoV-2 spike subunit 2–targeted vaccine could more effectively combat all human coronaviruses

One Health approach for emergent and resurgent infectious diseases

Tannins as therapeutic agents against SARS-CoV-2

Study explores the role of endemic coronaviruses-induced cross-immunity in protection against severe COVID-19

Proteomics profiling of COVID-19 patients identifies dysregulated proteins and pathways

Vaccination after COVID-19 recovery reduces reinfection risk by almost 50%

To what extent did the COVID-19 booster strategy prevent infections and hospitalizations in US adults?

Knowledge, attitudes, and practices of medical professionals towards monkeypox in Italy

AI-based tools have failed to reach the full diagnostic potential in COVID-19, study finds

Study investigates the combined effects of aging and HIV-1 Tat expression in mice

Moderna COVID vaccine is more effective in older and sicker veterans over time

Study highlights impaired ketogenesis as a potential confounder of severe COVID-19

The global mutation landscape of the SARS-CoV-2 non-structural protein 1

Study offers a method to calculate chances of catching Covid-19 on a plane flight

Exploring the G:Box and for high-quality imaging

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Latest News